| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.003 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.003 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |